Home Weight loss (GLP-1) By state Maryland
Maryland's GLP-1 Law (SB 496) Explained: 8 programs ship to MD
Maryland passed a law in 2026 that could open Medicaid to weight-loss drugs, and many headlines made it sound like coverage was already here. It isn't. Here is what the law actually allows, who is still left out, and how Marylanders get a GLP-1 at a fair cash price today. The lowest price we found from a program that ships to Maryland: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Maryland at a glance
- Maryland Medicaid
- Does not cover for weight loss
- State employee plan
- Does not cover for weight loss
- Adults with obesity
- 33.1% (2025)
- Programs we compare that ship to MD
- 8 of 22
Online GLP-1 programs for Maryland, cheapest first
Programs that ship to Maryland. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in Maryland: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Maryland: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
A new Maryland law, and what it does not do yet
Senate Bill 496 passed the General Assembly in April 2026 with wide margins. As amended, it lets the Maryland Medical Assistance Program cover obesity treatment, including FDA-approved weight-management drugs, starting January 1, 2027. The key word is lets. Lawmakers changed the bill from a mandate to an authorization. The state health department decides whether to offer the benefit and must apply to CMS first. The law also says the department must notify Medicaid members if it adds the benefit. Until then, Maryland Medicaid covers GLP-1s for type 2 diabetes and some other FDA-approved uses.
Cost is the reason for caution. The state fiscal note estimated about $449.4 million a year if Medicaid adds the coverage and a quarter of eligible members use it. Medicaid members should not expect weight-loss coverage before 2027, and possibly later. The law also asks the department to report on its decision, so watch for that. If you don't want to wait a year or more, a cash program can start you now.
State workers have no wait to look forward to: the 2026 state benefits guide lists weight-loss drugs as excluded. Commercial plans vary by employer, and many require prior authorization and proof of a lifestyle program. So a large share of Marylanders pay cash. The programs below serve Maryland, from Baltimore to the Eastern Shore, each with its own monthly price.
- SB 496 (2026) authorizes, but does not require, Maryland Medicaid to cover obesity treatment including FDA-approved weight-management drugs beginning January 1, 2027. (mgaleg.maryland.gov)
- The Department of Legislative Services fiscal note for SB 496 estimated Medicaid costs of about $449.4 million a year at 25% uptake. (mgaleg.maryland.gov)
- Maryland's 2026 state employee health benefits guide lists weight-loss drugs as excluded. (dbm.maryland.gov)
- 33.1% of Maryland adults had obesity in 2025 (CDC). (cdc.gov)
- Maryland Medicaid's combined Wegovy and Zepbound prior authorization form (MDH 12/2025) covers Wegovy for established cardiovascular disease with BMI 27+ or for MASH with F2 to F3 fibrosis. (health.maryland.gov)
- The same form covers Zepbound for moderate to severe obstructive sleep apnea (AHI 15+) with BMI 30+, requires a specialist, and asks for repeat sleep apnea documentation each year after 12 months. (health.maryland.gov)
- Maryland's Prescription Drug Affordability Board has voted to apply upper payment limits to Jardiance and Ozempic; state and local government plans may implement them from January 1, 2027. (pdab.maryland.gov)
- Board staff calculations set the baseline Ozempic upper payment limit at $274 per 30-day supply, based on the Medicare maximum fair price. (pdab.maryland.gov)
Maryland Medicaid's Wegovy and Zepbound form, line by line
While SB 496 waits on the health department, Maryland Medicaid already pays for Wegovy and Zepbound in narrow medical cases. The Office of Pharmacy Services uses one combined prior authorization form for both drugs, last revised in December 2025, and it shows exactly who qualifies today.
For Wegovy there are two routes. One is heart disease: a past heart attack, a past stroke, or symptomatic peripheral artery disease, plus a BMI of 27 or more recorded within the last 90 days, with the drug prescribed by or with a cardiologist. The other is MASH, a fatty liver disease with moderate to advanced scarring (stage F2 to F3), prescribed by or with a liver or digestive specialist. For Zepbound the route is sleep apnea: moderate to severe obstructive sleep apnea on a sleep study with 15 or more events an hour, a BMI of 30 or more within 90 days, and a sleep specialist, lung specialist or another clinician experienced in treating sleep apnea involved. Past 12 months, the apnea has to be documented again every year.
Every request also carries an attestation that the patient tried a weight-management program in the past six months without losing weight, and that the drug will be used with diet and exercise. None of this covers obesity on its own. If you do not have one of these diagnoses, you are in the group SB 496 may help from 2027, and in the meantime a cash program is the way to start.
The drug affordability board and its $274 Ozempic number
Maryland is one of the few states with a Prescription Drug Affordability Board that can cap what some public plans pay. In 2026 the board voted to set upper payment limits on two diabetes drugs, Jardiance and Ozempic. Its calculations for Ozempic set the baseline at $274 for a 30-day supply, which matches the price Medicare negotiated for 2027.
The cap is narrow. It applies to state and local government health plans, which may start using it on January 1, 2027 and must apply active limits after January 1, 2028. It does not change what a pharmacy charges you at the counter, it does not cover Wegovy prescriptions for weight loss, and the board's page notes that no limit is active yet. Still, it gives Marylanders a public reference point for what semaglutide can cost a large buyer.
When you compare cash programs, that number is a useful yardstick. Most compounded semaglutide plans in our comparison list a monthly price below it. Read what each monthly price includes before you decide, and check whether it changes with the dose.
Where Maryland stands between DC and West Virginia
Maryland's adult obesity rate was 33.1% in CDC's 2025 survey. Its neighbors spread widely around that number: the District of Columbia at 24.2%, Pennsylvania at 33.5%, Virginia at 34.2%, Delaware at 36.3% and West Virginia at 37.4%. Maryland sits in the middle of its region, with roughly one adult in three affected.
Coverage around the region differs just as much. Delaware's Medicaid pays for weight-loss GLP-1s with prior authorization, while Maryland's waits on a decision under SB 496. People who live near a state line sometimes assume they can use a neighbor's rules, but Medicaid and state employee coverage follow the state where you are enrolled. Online prescriptions follow where you live, too: the clinician must be licensed in Maryland, and the program must ship to a Maryland address. Every program in our comparison serves the whole state, from Western Maryland to Ocean City.
GLP-1 in Maryland: questions
Does Maryland Medicaid cover GLP-1s for weight loss after SB 496?
Not yet. SB 496 allows Maryland Medicaid to cover weight-loss drugs starting January 1, 2027, but it does not require it. The state health department must choose to offer the benefit and get CMS approval. Until then, Medicaid covers GLP-1s for type 2 diabetes and some other conditions. Cash programs are the main route for weight loss now.
Are Wegovy and Zepbound covered for Maryland state employees?
No. The 2026 Maryland state employee benefits guide lists weight-loss drugs as excluded. GLP-1s for diabetes follow the normal prescription benefit. State workers who want a GLP-1 for weight loss can compare online programs on this page, where each program lists what its monthly price includes.
How do I get a GLP-1 prescription online in Maryland?
Pick a program that serves Maryland, complete a health questionnaire, and a clinician licensed in Maryland reviews it, often by video. Some ask for recent lab work. If you qualify, the medication ships to your home. The whole process usually takes a few days. Every program listed here is confirmed to serve Maryland.
Would SB 496 help people with private insurance in Maryland?
No. The law only concerns Maryland Medicaid. Commercial plans set their own rules, and many cover GLP-1s for weight loss only if the employer bought that benefit, often with prior authorization. If your plan says no, the cash prices below are usually far lower than the brand list price of over $1,000 a month.
What does tirzepatide cost in Maryland if I pay myself?
Compounded tirzepatide from online programs often keeps one price at every dose, which saves money once you reach a maintenance dose. In November 2026 Maximus, which serves Maryland, priced it from $99.99 a month on a 12-month plan. Maximus also sells brand-name Zepbound, which starts at a higher price. Compare both on this page.
Does Maryland Medicaid cover Zepbound for sleep apnea?
Yes, with prior authorization. The state form asks for a sleep study showing moderate to severe obstructive sleep apnea, a BMI of 30 or more in the last 90 days, and a sleep specialist, lung specialist or another clinician experienced with sleep apnea on the case. After a year, the apnea must be documented again annually.
Does Maryland's Ozempic price cap lower what I pay?
Not directly. The upper payment limit applies to state and local government health plans, optionally from January 2027 and required after January 2028. It does not set pharmacy cash prices and it applies to Ozempic, not to Wegovy or Zepbound. Compare cash programs in our table for today's prices.
Can I get compounded semaglutide in Baltimore?
Yes. Online programs serve Baltimore City and County and the rest of Maryland. A clinician licensed in Maryland reviews your health form, and the medication ships to you. Compare the monthly price, the plan length it requires, and what follow-up care is included before you choose.
See programs for Maryland All states
Sources: kff.org · cdc.gov · dbm.maryland.gov